Location: Mountain View, CA
CIK: 0001652044 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Nov 15, 2022
Total Value: $1.19B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JD | JD com Inc | 13,553,474 | $528M | 44.3% | $38.95 | — | SPON ADR CL A | 47215P106 |
| — | Arris Intl Inc | 9,703,500 | $237M | 19.9% | $22.92 | — | SHS | G0551A103 |
| ZS | Zscaler Inc | 2,788,560 | $99.69M | 8.4% | $29.28 | +4.2% | COM | 98980G102 |
| DOCU | DocuSign Inc | 1,461,106 | $77.37M | 6.5% | $50.48 | 0.0% | COM | 256163106 |
| RCUS | Arcus Biosciences Inc | 5,049,786 | $61.81M | 5.2% | $16.66 | -5.8% | COM | 03969F109 |
| — | Magenta Therapeutics Inc | 3,339,138 | $45.08M | 3.8% | $13.50 | — | COM | 55910K108 |
| SNAP | Snap Inc | 2,618,548 | $34.28M | 2.9% | $22.16 | -41.8% | CL A | 83304A106 |
| — | Forty Seven Inc | 1,545,966 | $24.73M | 2.1% | $16.00 | — | COM | 34983P104 |
| AUTL | Autolus Therapeutics PLC | 714,072 | $19.13M | 1.6% | $26.79 | — | SPON ADS | 05280R100 |
| SPRO | Spero Therapeutics Inc | 1,112,473 | $16.32M | 1.4% | $12.27 | +4.2% | COM | 84833T103 |
| — | Evelo Biosciences Inc | 1,060,495 | $12.51M | 1.1% | $11.80 | — | COM | 299734103 |
| — | Cloudera Inc | 855,420 | $11.67M | 1.0% | $16.02 | — | COM | 18914U100 |
| — | Arsanis Inc | 451,362 | $9.831M | 0.8% | $76.56 | — | COM | 042873109 |
| DNLI | Denali Therapeutics Inc | 536,411 | $8.18M | 0.7% | $17.97 | +4.8% | COM | 24823R105 |
| — | Pluralsight Inc | 101,442 | $2.48M | 0.2% | $24.45 | — | CL A | 72941B106 |
| XYZ | Square Inc | 29,400 | $1.812M | 0.2% | $36.61 | +50.2% | CL A | 852234103 |
| DBX | Dropbox Inc | 13,033 | $423K | 0.0% | $30.21 | +3.5% | CL A | 26210C104 |